Financhill
Buy
56

IHHHF Quote, Financials, Valuation and Earnings

Last price:
$1.19
Seasonality move :
1.53%
Day range:
$1.19 - $1.19
52-week range:
$1.19 - $1.19
Dividend yield:
1.89%
P/E ratio:
18.42x
P/S ratio:
2.12x
P/B ratio:
1.52x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$10.5B
Revenue:
$4.6B
EPS (TTM):
$0.06

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IHHHF
IHH Healthcare Bhd
-- -- -- -- --
AIM
AIM ImmunoTech
$100K -$0.09 -23.08% -53.85% $2.75
CVM
CEL-SCI
-- -- -- -- $7.73
KSRBF
Kossan Rubber Industries Bhd
-- -- -- -- --
SPMXF
Supermax Corp Bhd
-- -- -- -- --
TGLVY
Top Glove Corp Bhd
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IHHHF
IHH Healthcare Bhd
$1.19 -- $10.5B 18.42x $0.01 1.89% 2.12x
AIM
AIM ImmunoTech
$0.23 $2.75 $14.9M -- $0.00 0% 64.14x
CVM
CEL-SCI
$0.40 $7.73 $25.4M -- $0.00 0% --
KSRBF
Kossan Rubber Industries Bhd
$0.27 -- $688.9M 34.77x $0.02 4.82% 1.78x
SPMXF
Supermax Corp Bhd
$0.18 -- $458.6M -- $0.01 0% 3.09x
TGLVY
Top Glove Corp Bhd
$0.92 -- $1.8B -- $0.00 0% 2.89x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IHHHF
IHH Healthcare Bhd
20.75% 0.014 16.14% 0.75x
AIM
AIM ImmunoTech
48.41% 0.799 17.25% 0.71x
CVM
CEL-SCI
-- 0.840 -- --
KSRBF
Kossan Rubber Industries Bhd
1.81% -0.275 2.45% 8.37x
SPMXF
Supermax Corp Bhd
3.24% 0.000 7.27% 4.66x
TGLVY
Top Glove Corp Bhd
6.16% -3.726 6.54% 1.55x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IHHHF
IHH Healthcare Bhd
$910.5M $205.5M 6.41% 8.04% 17.3% $121.2M
AIM
AIM ImmunoTech
$27K -$4.5M -219.06% -256.33% -9994.29% -$3.3M
CVM
CEL-SCI
-- -$6.7M -- -- -- -$4.6M
KSRBF
Kossan Rubber Industries Bhd
-- $9M 2.33% 2.35% 7.91% -$57.1M
SPMXF
Supermax Corp Bhd
-- -$18.1M -5.08% -5.19% -35.85% $8M
TGLVY
Top Glove Corp Bhd
-- $1.1M 0.71% 0.77% 2.31% -$7.4M

IHH Healthcare Bhd vs. Competitors

  • Which has Higher Returns IHHHF or AIM?

    AIM ImmunoTech has a net margin of 9.46% compared to IHH Healthcare Bhd's net margin of -10571.43%. IHH Healthcare Bhd's return on equity of 8.04% beat AIM ImmunoTech's return on equity of -256.33%.

    Company Gross Margin Earnings Per Share Invested Capital
    IHHHF
    IHH Healthcare Bhd
    71.82% $0.01 $9.4B
    AIM
    AIM ImmunoTech
    77.14% -$0.06 $5.6M
  • What do Analysts Say About IHHHF or AIM?

    IHH Healthcare Bhd has a consensus price target of --, signalling downside risk potential of --. On the other hand AIM ImmunoTech has an analysts' consensus of $2.75 which suggests that it could grow by 1078.24%. Given that AIM ImmunoTech has higher upside potential than IHH Healthcare Bhd, analysts believe AIM ImmunoTech is more attractive than IHH Healthcare Bhd.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHHHF
    IHH Healthcare Bhd
    0 0 0
    AIM
    AIM ImmunoTech
    1 0 0
  • Is IHHHF or AIM More Risky?

    IHH Healthcare Bhd has a beta of -0.045, which suggesting that the stock is 104.538% less volatile than S&P 500. In comparison AIM ImmunoTech has a beta of -0.363, suggesting its less volatile than the S&P 500 by 136.26%.

  • Which is a Better Dividend Stock IHHHF or AIM?

    IHH Healthcare Bhd has a quarterly dividend of $0.01 per share corresponding to a yield of 1.89%. AIM ImmunoTech offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IHH Healthcare Bhd pays 59.97% of its earnings as a dividend. AIM ImmunoTech pays out -- of its earnings as a dividend. IHH Healthcare Bhd's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IHHHF or AIM?

    IHH Healthcare Bhd quarterly revenues are $1.3B, which are larger than AIM ImmunoTech quarterly revenues of $35K. IHH Healthcare Bhd's net income of $120M is higher than AIM ImmunoTech's net income of -$3.7M. Notably, IHH Healthcare Bhd's price-to-earnings ratio is 18.42x while AIM ImmunoTech's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IHH Healthcare Bhd is 2.12x versus 64.14x for AIM ImmunoTech. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHHHF
    IHH Healthcare Bhd
    2.12x 18.42x $1.3B $120M
    AIM
    AIM ImmunoTech
    64.14x -- $35K -$3.7M
  • Which has Higher Returns IHHHF or CVM?

    CEL-SCI has a net margin of 9.46% compared to IHH Healthcare Bhd's net margin of --. IHH Healthcare Bhd's return on equity of 8.04% beat CEL-SCI's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IHHHF
    IHH Healthcare Bhd
    71.82% $0.01 $9.4B
    CVM
    CEL-SCI
    -- -$0.14 --
  • What do Analysts Say About IHHHF or CVM?

    IHH Healthcare Bhd has a consensus price target of --, signalling downside risk potential of --. On the other hand CEL-SCI has an analysts' consensus of $7.73 which suggests that it could grow by 1843.54%. Given that CEL-SCI has higher upside potential than IHH Healthcare Bhd, analysts believe CEL-SCI is more attractive than IHH Healthcare Bhd.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHHHF
    IHH Healthcare Bhd
    0 0 0
    CVM
    CEL-SCI
    1 0 0
  • Is IHHHF or CVM More Risky?

    IHH Healthcare Bhd has a beta of -0.045, which suggesting that the stock is 104.538% less volatile than S&P 500. In comparison CEL-SCI has a beta of 0.653, suggesting its less volatile than the S&P 500 by 34.718%.

  • Which is a Better Dividend Stock IHHHF or CVM?

    IHH Healthcare Bhd has a quarterly dividend of $0.01 per share corresponding to a yield of 1.89%. CEL-SCI offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IHH Healthcare Bhd pays 59.97% of its earnings as a dividend. CEL-SCI pays out -- of its earnings as a dividend. IHH Healthcare Bhd's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IHHHF or CVM?

    IHH Healthcare Bhd quarterly revenues are $1.3B, which are larger than CEL-SCI quarterly revenues of --. IHH Healthcare Bhd's net income of $120M is higher than CEL-SCI's net income of -$6.9M. Notably, IHH Healthcare Bhd's price-to-earnings ratio is 18.42x while CEL-SCI's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IHH Healthcare Bhd is 2.12x versus -- for CEL-SCI. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHHHF
    IHH Healthcare Bhd
    2.12x 18.42x $1.3B $120M
    CVM
    CEL-SCI
    -- -- -- -$6.9M
  • Which has Higher Returns IHHHF or KSRBF?

    Kossan Rubber Industries Bhd has a net margin of 9.46% compared to IHH Healthcare Bhd's net margin of 5.8%. IHH Healthcare Bhd's return on equity of 8.04% beat Kossan Rubber Industries Bhd's return on equity of 2.35%.

    Company Gross Margin Earnings Per Share Invested Capital
    IHHHF
    IHH Healthcare Bhd
    71.82% $0.01 $9.4B
    KSRBF
    Kossan Rubber Industries Bhd
    -- $0.00 $952.6M
  • What do Analysts Say About IHHHF or KSRBF?

    IHH Healthcare Bhd has a consensus price target of --, signalling downside risk potential of --. On the other hand Kossan Rubber Industries Bhd has an analysts' consensus of -- which suggests that it could fall by --. Given that IHH Healthcare Bhd has higher upside potential than Kossan Rubber Industries Bhd, analysts believe IHH Healthcare Bhd is more attractive than Kossan Rubber Industries Bhd.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHHHF
    IHH Healthcare Bhd
    0 0 0
    KSRBF
    Kossan Rubber Industries Bhd
    0 0 0
  • Is IHHHF or KSRBF More Risky?

    IHH Healthcare Bhd has a beta of -0.045, which suggesting that the stock is 104.538% less volatile than S&P 500. In comparison Kossan Rubber Industries Bhd has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock IHHHF or KSRBF?

    IHH Healthcare Bhd has a quarterly dividend of $0.01 per share corresponding to a yield of 1.89%. Kossan Rubber Industries Bhd offers a yield of 4.82% to investors and pays a quarterly dividend of $0.02 per share. IHH Healthcare Bhd pays 59.97% of its earnings as a dividend. Kossan Rubber Industries Bhd pays out 478.29% of its earnings as a dividend. IHH Healthcare Bhd's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Kossan Rubber Industries Bhd's is not.

  • Which has Better Financial Ratios IHHHF or KSRBF?

    IHH Healthcare Bhd quarterly revenues are $1.3B, which are larger than Kossan Rubber Industries Bhd quarterly revenues of $114M. IHH Healthcare Bhd's net income of $120M is higher than Kossan Rubber Industries Bhd's net income of $6.6M. Notably, IHH Healthcare Bhd's price-to-earnings ratio is 18.42x while Kossan Rubber Industries Bhd's PE ratio is 34.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IHH Healthcare Bhd is 2.12x versus 1.78x for Kossan Rubber Industries Bhd. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHHHF
    IHH Healthcare Bhd
    2.12x 18.42x $1.3B $120M
    KSRBF
    Kossan Rubber Industries Bhd
    1.78x 34.77x $114M $6.6M
  • Which has Higher Returns IHHHF or SPMXF?

    Supermax Corp Bhd has a net margin of 9.46% compared to IHH Healthcare Bhd's net margin of -28.77%. IHH Healthcare Bhd's return on equity of 8.04% beat Supermax Corp Bhd's return on equity of -5.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    IHHHF
    IHH Healthcare Bhd
    71.82% $0.01 $9.4B
    SPMXF
    Supermax Corp Bhd
    -- -$0.01 $1B
  • What do Analysts Say About IHHHF or SPMXF?

    IHH Healthcare Bhd has a consensus price target of --, signalling downside risk potential of --. On the other hand Supermax Corp Bhd has an analysts' consensus of -- which suggests that it could fall by --. Given that IHH Healthcare Bhd has higher upside potential than Supermax Corp Bhd, analysts believe IHH Healthcare Bhd is more attractive than Supermax Corp Bhd.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHHHF
    IHH Healthcare Bhd
    0 0 0
    SPMXF
    Supermax Corp Bhd
    0 0 0
  • Is IHHHF or SPMXF More Risky?

    IHH Healthcare Bhd has a beta of -0.045, which suggesting that the stock is 104.538% less volatile than S&P 500. In comparison Supermax Corp Bhd has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock IHHHF or SPMXF?

    IHH Healthcare Bhd has a quarterly dividend of $0.01 per share corresponding to a yield of 1.89%. Supermax Corp Bhd offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. IHH Healthcare Bhd pays 59.97% of its earnings as a dividend. Supermax Corp Bhd pays out -52.24% of its earnings as a dividend. IHH Healthcare Bhd's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IHHHF or SPMXF?

    IHH Healthcare Bhd quarterly revenues are $1.3B, which are larger than Supermax Corp Bhd quarterly revenues of $50.5M. IHH Healthcare Bhd's net income of $120M is higher than Supermax Corp Bhd's net income of -$14.5M. Notably, IHH Healthcare Bhd's price-to-earnings ratio is 18.42x while Supermax Corp Bhd's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IHH Healthcare Bhd is 2.12x versus 3.09x for Supermax Corp Bhd. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHHHF
    IHH Healthcare Bhd
    2.12x 18.42x $1.3B $120M
    SPMXF
    Supermax Corp Bhd
    3.09x -- $50.5M -$14.5M
  • Which has Higher Returns IHHHF or TGLVY?

    Top Glove Corp Bhd has a net margin of 9.46% compared to IHH Healthcare Bhd's net margin of 1.94%. IHH Healthcare Bhd's return on equity of 8.04% beat Top Glove Corp Bhd's return on equity of 0.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    IHHHF
    IHH Healthcare Bhd
    71.82% $0.01 $9.4B
    TGLVY
    Top Glove Corp Bhd
    -- $0.00 $1.4B
  • What do Analysts Say About IHHHF or TGLVY?

    IHH Healthcare Bhd has a consensus price target of --, signalling downside risk potential of --. On the other hand Top Glove Corp Bhd has an analysts' consensus of -- which suggests that it could fall by --. Given that IHH Healthcare Bhd has higher upside potential than Top Glove Corp Bhd, analysts believe IHH Healthcare Bhd is more attractive than Top Glove Corp Bhd.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHHHF
    IHH Healthcare Bhd
    0 0 0
    TGLVY
    Top Glove Corp Bhd
    0 0 0
  • Is IHHHF or TGLVY More Risky?

    IHH Healthcare Bhd has a beta of -0.045, which suggesting that the stock is 104.538% less volatile than S&P 500. In comparison Top Glove Corp Bhd has a beta of 0.831, suggesting its less volatile than the S&P 500 by 16.934%.

  • Which is a Better Dividend Stock IHHHF or TGLVY?

    IHH Healthcare Bhd has a quarterly dividend of $0.01 per share corresponding to a yield of 1.89%. Top Glove Corp Bhd offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IHH Healthcare Bhd pays 59.97% of its earnings as a dividend. Top Glove Corp Bhd pays out -- of its earnings as a dividend. IHH Healthcare Bhd's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IHHHF or TGLVY?

    IHH Healthcare Bhd quarterly revenues are $1.3B, which are larger than Top Glove Corp Bhd quarterly revenues of $204.5M. IHH Healthcare Bhd's net income of $120M is higher than Top Glove Corp Bhd's net income of $4M. Notably, IHH Healthcare Bhd's price-to-earnings ratio is 18.42x while Top Glove Corp Bhd's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IHH Healthcare Bhd is 2.12x versus 2.89x for Top Glove Corp Bhd. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHHHF
    IHH Healthcare Bhd
    2.12x 18.42x $1.3B $120M
    TGLVY
    Top Glove Corp Bhd
    2.89x -- $204.5M $4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is up 22.25% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 20.59% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 19.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock